Salvage surgery for advanced non-small cell lung cancer after response to gefitinib

被引：38
|
作者：
Hishida, Tomoyuki [1 ]
Nagai, Kanji [1 ]
Mitsudomi, Tetsuya [2 ]
Yokoi, Kohei [3 ]
Kondo, Haruhiko [4 ]
Horinouchi, Hirohisa [5 ]
Akiyama, Hirohiko [6 ]
Nagayasu, Takeshi [7 ]
Tsuboi, Masahiro [8 ]
机构：
[1] Natl Canc Ctr Hosp E, Div Thorac Surg, Chiba 2778577, Japan
[2] Aichi Canc Ctr Hosp, Div Thorac Surg, Aichi, Japan
[3] Nagoya Univ, Grad Sch Med, Div Thorac Surg, Aichi, Japan
[4] Shizuoka Canc Ctr Hosp, Div Thorac Surg, Shizuoka, Japan
[5] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan
[6] Saitama Canc Ctr Hosp, Div Thorac Surg, Saitama, Japan
[7] Nagasaki Univ, Grad Sch Biomed Sci, Dept Translat Med Sci, Div Surg Oncol, Nagasaki 852, Japan
[8] Kanagawa Canc Ctr Hosp, Dept Thorac Surg, Kanagawa, Japan
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2010年 / 140卷 / 05期
关键词：
ADENOCARCINOMA; MUTATION;
D O I：
10.1016/j.jtcvs.2010.06.035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E69 / E71
页数：4
相关论文
共 50 条
  • [1] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [2] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [3] Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
    Song Zheng-bo
    Yu Yong-feng
    Chen Zhi-wei
    Lu Shun
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (15) : 2279 - 2283
  • [4] Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
    SONG ZhengboYU YongfengCHEN Zhiwei and LU Shun Shanghai Lung Tumor Clinical Medical CenterChest Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China
    [J]. 中华医学杂志(英文版), 2011, (15) : 2279 - 2283
  • [5] Gefitinib (Iressa) for advanced non-small cell lung cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1138): : 77 - 78
  • [6] Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer
    Viswanathan, A
    Pillot, G
    Govindan, R
    [J]. LUNG CANCER, 2005, 50 (03) : 417 - 418
  • [7] Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series
    Song, Weian
    Di, Shouyin
    Liu, Junqiang
    Fan, Boshi
    Zhao, Jiahua
    Zhou, Shaohua
    Chen, Siyu
    Dong, Hai
    Yue, Caiying
    Gong, Taiqian
    [J]. THORACIC CANCER, 2020, 11 (04) : 1061 - 1067
  • [8] Salvage Surgery After Definitive Chemoradiotherapy for Non-Small Cell Lung Cancer
    Lampridis, Savvas
    [J]. ANNALS OF THORACIC SURGERY, 2021, 112 (06): : 2108 - 2108
  • [9] Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy
    Shimizu, Kimihiro
    Ohtaki, Yoichi
    Suzuki, Kenji
    Date, Hiroshi
    Yamashita, Motohiro
    Iizasa, Toshihiko
    Ito, Hiroyuki
    Yoshimura, Kenichi
    Okada, Morihito
    Chida, Masayuki
    [J]. ANNALS OF THORACIC SURGERY, 2021, 112 (03): : 862 - 873
  • [10] Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer
    Casiraghi, Monica
    Maisonneuve, Patrick
    Piperno, Gaia
    Bellini, Roberto
    Brambilla, Daniela
    Petrella, Francesco
    De Marinis, Filippo
    Spaggiari, Lorenzo
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (02) : 233 - 241
12345